The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App 
Professionals >> Visit The Body PROThe Body en Espanol
Ask the Experts About

Choosing Your MedsChoosing Your Meds
Rollover images to visit our other forums!
Recent AnswersAsk a Question
  • Email Email
  • Glossary Glossary

mitochondrial toxicity

May 23, 2002

Which drugs in the na class(including tenofovir)have the least about of mitochondrial toxcity VS. the most,or are they all pretty much the same?

Response from Dr. Young

Thanks for the question.

The issue of mitochondrial toxicity has gain a lot of recent attention. It is clear that mitochondrial toxicity is associated with lactic acidosis, pancreatitis, and certain types of muscle injury; there is conjecture (though pretty strong) that there may be association with other types of toxicities (lipodystrophy, for example).

The nucleoside/nuecleotide inhibitors differ with regard to their relative mitochondrial toxicities. Recent data (Birku, 9th Conference on Retroviruses, 2002) supports the idea that tenofovir, abacavir and lamivudine (3TC) cause the least amount of injury. Other nucleosides cause increasing amounts of injury (as measured by mitochondrial DNA levels): AZT< d4T< ddI < ddC.

I hope this is helpful, BY

low platlet coung
Thailand help again.

  • Email Email
  • Glossary Glossary

 Get Email Notifications When This Forum Updates or Subscribe With RSS



This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.

Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.

Review our complete terms of use and copyright notice.

Powered by ExpertViewpoint